Madison Investment Advisors LLC Invests $2.04 Million in Humana Inc. (NYSE:HUM)

Madison Investment Advisors LLC bought a new stake in Humana Inc. (NYSE:HUM) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 8,032 shares of the insurance provider’s stock, valued at approximately $2,038,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HUM. Quest Partners LLC purchased a new stake in Humana in the 3rd quarter valued at approximately $701,000. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Humana in the 3rd quarter valued at approximately $1,778,000. Moors & Cabot Inc. lifted its stake in Humana by 2.5% in the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after buying an additional 40 shares in the last quarter. Cornerstone Advisors LLC lifted its stake in Humana by 5.0% in the 3rd quarter. Cornerstone Advisors LLC now owns 4,200 shares of the insurance provider’s stock valued at $1,330,000 after buying an additional 200 shares in the last quarter. Finally, Landscape Capital Management L.L.C. lifted its stake in Humana by 54.4% in the 3rd quarter. Landscape Capital Management L.L.C. now owns 2,451 shares of the insurance provider’s stock valued at $776,000 after buying an additional 864 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the topic of a number of recent research reports. Truist Financial upped their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Piper Sandler boosted their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. StockNews.com downgraded Humana from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, Barclays boosted their price target on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Nineteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, Humana presently has an average rating of “Hold” and a consensus price target of $285.68.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.37% of the company’s stock.

Humana Price Performance

Shares of NYSE:HUM opened at $266.33 on Friday. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The stock has a fifty day moving average of $271.33 and a 200-day moving average of $277.52. The company has a market capitalization of $32.14 billion, a PE ratio of 26.77, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. Humana’s payout ratio is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.